HOME >> MEDICINE >> NEWS
Controversial Atkins Diet may be beneficial for people with epilepsy

Imagine that your child with epilepsy could have seizures less frequently, by eating more protein and less carbs. The first comprehensive review of possible dietary treatments of epilepsy has recently been published. Among those dietary regimens is the low-carbohydrate Atkins Diet which has proven successful in suppressing epileptic seizures in a small series of patients. The review, published in Epilepsy Currents, explores the benefits of low-carb, high protein, and other restricted dietary therapies for patients with epilepsy.

There are a number of diets being tried to help people with epilepsy. The ketogenic diet (KD), a high fat, adequate protein, and low carbohydrate diet, is the most well known of dietary therapies amongst the epilepsy community. It was initially devised in 1921 to "mimic the anticonvulsant effects of fasting, which were known to suppress seizures." Because the KD is high in fat and low in carbohydrates, the body is forced to burn fat for energy, a process called ketosis. The review explains that this shift in energy results in an anticonvulsant effect, though the exact mechanisms are still not fully understood.

Another treatment, still in preliminary stages, is a diet high in polyunsaturated fatty acids (PUFA). This may be another option to control seizures. A diet enriched in PUFA has shown to help in brain development and decreases the excitability of nerve cells that can induce seizures. Additionally, a diet high in PUFA may help against the degenerative effects of Alzheimer disease.

These diets have been successful to a point, but each has drawbacks in terms of implementation. As success has been observed with the Atkins diet, people with epilepsy might find this diet to be easier to follow.

"Unfortunately, our knowledge about the relation between nutrition and epilepsy is in its infancy," states author Dr. Carl E. Stafstrom. "Aside from the ketogenic diet, nutritional modalities to treat epilepsy
'"/>

Contact: Sharon Agsalda
medicalnews@bos.blackwellpublishing.net
1-781-388-8507
Blackwell Publishing Ltd.
31-Jan-2005


Page: 1 2

Related medicine news :

1. Controversial drug shown to act on brain protein to cut alcohol use
2. Controversial performance enhancer "andro" affects brains as well as brawn, say UMass researchers
3. Atkins-Type dieters report new cases of serious illness
4. Sharing clinical trial results with participants may be beneficial
5. Two studies find evidence that sunlight may have beneficial influence on cancer
6. Drinking water could be beneficial to patients with low blood pressure
7. One form of vitamin E appears beneficial in reducing bladder cancer risk
8. Drinking extra fluids during a cold may not be beneficial
9. Probiotics beneficial even when inactive, according to UCSD study
10. Home-based therapy beneficial for stroke patients
11. Buckwheat may be beneficial for managing diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Controversial Atkins Diet may beneficial for people with epilepsy

(Date:6/19/2013)... 2013 In honor of women everywhere, ... providing information that women can use to improve their ... women should pay close attention to their health, as ... changes a woman’s body undergoes while pregnant can increase ... says Dr. Ray Workman, a leading vein doctor at ...
(Date:6/19/2013)... Washington, DC (PRWEB) June 19, 2013 ... experiment in the history of managed care. As ... find coverage through the new state-based and federally ... requirements for essential health benefits, and examples of ... some states, industry-leading health business information publisher Atlantic ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Scott Tischler of ... curb this swim suit season. , 1.    The very first thing ... big tall glass of ice cold water. The body is ... water. This will keep the body hydrated and will also ... body has to raise the temperature of the water to ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 As Mirena ... LLP highlights a recent news story from an NBC ... effects of the hormone-based contraceptive device. The Rottenstein Law ... to file Mirena lawsuits and who are ... The U.S. Food and Drug Administration has logged more ...
(Date:6/19/2013)... Transvaginal mesh lawsuits are moving along in the New ... how to handle evidence in the C.R. Bard lawsuits, specifically ... components removed from patients. The Rottenstein Law Group LLP maintains ... about the device and a guide on how to file ... the medical facilities that currently hold them and are to ...
Breaking Medicine News(10 mins):Health News:Novant Health Vein Specialists Promotes Women’s Health with Social Media Campaign 2Health News:New Special Report Provides Comprehensive Overview of New Health Insurance Exchange Marketplaces 2Health News:Rottenstein Law Group LLP Comments on News Reports of Mirena IUD Side Effects 2Health News:Transvaginal Mesh Lawsuit News: NJ Mesh Consolidation Cases Moving Along, Rottenstein Law Group LLP Reports 2
(Date:6/18/2013)... , June 18, 2013  Isis Pharmaceuticals, Inc. (NASDAQ: ... that management will present a general corporate update in conjunction ... on Tuesday, June 25 at 2:10 p.m. Pacific Time in ... for the meeting is as follows: 2:00 p.m. – 2:10 ... as of April 26, 2013) 2:10 p.m. – 3:15 p.m. ...
(Date:6/17/2013)... WASHINGTON , June 17, 2013 ... ) presented additional data today at ENDO 2013, ... demonstrating that tasimelteon can entrain (synchronize) both melatonin ... potential to reset the master body clock and ... Non-24-Hour Disorder (Non-24).  The SET (Safety and Efficacy ...
(Date:6/17/2013)... June 17, 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... it has filed a preliminary prospectus supplement to its effective ... a similar filing with securities regulatory authorities in each of ... with a public offering of its common shares to raise ... The Company will also grant to the underwriters of the ...
Breaking Medicine Technology:Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4
Cached News: